FDANonrulemakingFDA-2025-P-5437
Who commented on this docket
Requests that the FDA revisit the approval of the Abbreviate New Drug Application 216616, a generic version of Mifepristone, to requires the inclusion of a provision in all Prescriber Requirements that a Catch-Kit and Red Medical Waste Bag be included with Mifepristone Prescriptions
2 organizations filed 2 public comments on Requests that the FDA revisit the approval of the Abbreviate New Drug Application 216616, a generic version of Mifepristone, to requires the inclusion of a provision in all Prescriber Requirements that a Catch-Kit and Red Medical Waste Bag be included with Mifepristone Prescriptions, at the Food and Drug Administration.
Organizations
2
Comments
2
RIN
—
Comment window
—
Abstract
Open
Commenters (2)
- Center for Biological Diversity1 filing · confidence 97%
- Guttmacher Institutetrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.